FDA Inspection 1273955 — Atul Manohar Gurav, MBBS
The FDA completed an inspection of Atul Manohar Gurav, MBBS on June 25, 2025 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bengaluru (India)
Additional Details
Clinical BA/BE